Newly synthesized hepatitis C virus replicon RNA is protected from nuclease activity by a protease-sensitive factor(s)

J Virol. 2004 Sep;78(18):10202-5. doi: 10.1128/JVI.78.18.10202-10205.2004.

Abstract

Biochemical characterization of hepatitis C virus (HCV) replication using purified, membrane-associated replication complexes is hampered by the presence of endogenous nuclease activity that copurifies with the replication complex. In this study, pulse-chase analyses were used to demonstrate that newly synthesized replicon RNA was protected from nuclease activity by a factor(s) that was sensitive to 0.5% NP-40 or protease treatment. Nuclease susceptibility was not related to disruption of lipid membranes, since NP-40 did not significantly affect the buoyant density of HCV replication complexes or protease susceptibility of HCV NS3 and NS5A proteins. These results suggest that a protease-sensitive factor(s) protects newly synthesized RNA from nuclease degradation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Endopeptidases / metabolism
  • Hepacivirus / genetics*
  • Hepacivirus / physiology
  • Humans
  • Octoxynol
  • Polyethylene Glycols / pharmacology
  • RNA, Viral / genetics*
  • RNA, Viral / metabolism*
  • Replicon
  • Ribonucleases / metabolism
  • Viral Nonstructural Proteins / metabolism
  • Virus Replication

Substances

  • NS3 protein, hepatitis C virus
  • RNA, Viral
  • Viral Nonstructural Proteins
  • Polyethylene Glycols
  • Octoxynol
  • Nonidet P-40
  • NS-5 protein, hepatitis C virus
  • Ribonucleases
  • Endopeptidases